Sec. 1014. MACPAC study and report on MAT utilization controls under State Medicaid programs
189 words·~1 min read·
/bill/115/hr/6/eah/section-1014A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Medicaid and CHIP Payment and Access Commission shall conduct a study and analysis of utilization control policies applied to medication-assisted treatment for substance use disorders under State Medicaid programs, including policies and procedures applied both in fee-for-service Medicaid and in risk-based managed care Medicaid, which shall— include an inventory of such utilization control policies and related protocols for ensuring access to medically necessary treatment; determine whether managed care utilization control policies and procedures for medication-assisted treatment for substance use disorders are consistent with section 438.210(a)(4)(ii) of title 42, Code of Federal Regulations; and identify policies that— limit an individual's access to medication-assisted treatment for a substance use disorder by limiting the quantity of medication-assisted treatment prescriptions, or the number of refills for such prescriptions, available to the individual as part of a prior authorization process or similar utilization protocols; and apply without evaluating individual instances of fraud, waste, or abuse.
Not later than 1 year after the date of the enactment of this Act, the Medicaid and CHIP Payment and Access Commission shall make publicly available a report containing the results of the study conducted under subsection (a).